Arbutus Biopharma Corp Human Resources Contracts & Agreements
49 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Confidentiality Agreements (21)
- Consulting Agreements (3)
- Employment Agreements (14)
- Separation Agreements (3)
- Severance Agreements (2)
- Consulting Agreement, dated effective July 7, 2023, by and between Elizabeth A. Howard and Arbutus Biopharma Corporation (Filed With SEC on March 5, 2024)
- Separation and Release Agreement, dated effective as of July 7, 2023, between Arbutus Biopharma Corporation and Elizabeth A. Howard (Filed With SEC on March 5, 2024)
- Fourth Amendment to Executive Employment Agreement, dated January 1, 2024, by and between Michael McElhaugh and Arbutus Biopharma, Inc (Filed With SEC on January 4, 2024)
- Consulting Agreement, effective December 31, 2023, by and between William Collier and Arbutus Biopharma Corporation (Filed With SEC on January 4, 2024)
- Separation and Release Agreement, dated December 31, 2023, by and between William Collier and Arbutus Biopharma Corporation (Filed With SEC on January 4, 2024)
- Executive Employment Agreement, dated effective as of July 10, 2023, between Arbutus Biopharma, Inc. and J. Christopher Naftzger (Filed With SEC on August 3, 2023)
- Executive Employment Agreement, dated effective as of July 10, 2023, between Arbutus Biopharma, Inc. and Karen Sims, MD, PhD (Filed With SEC on August 3, 2023)
- Third Amendment to Executive Employment Agreement, dated (Filed With SEC on October 24, 2022)
- Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan, as supplemented and amended (Filed With SEC on May 31, 2022)
- Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan, as supplemented and amended (Filed With SEC on June 1, 2021)
- Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan, as supplemented and amended (Filed With SEC on June 1, 2020)
- Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan, as supplemented (Filed With SEC on August 5, 2019)
- Employment Agreement, dated June 13, 2019, by and between Arbutus Biopharma Corporation and William H. Collier (Filed With SEC on June 18, 2019)
- Consulting Agreement, dated June 13, 2019, by and between Arbutus Biopharma, Inc. and Mark J. Murray (Filed With SEC on June 18, 2019)
- Separation Agreement and Release, dated June 13, 2019, by and between Arbutus Biopharma Corporation and Mark J. Murray (Filed With SEC on June 18, 2019)
- Koert VandenEnden Termination and Severance Agreement (Filed With SEC on May 6, 2019)
- Executive Signing Bonus, dated May 28, 2018, by and between the Company and David Hasting (Filed With SEC on March 7, 2019)
- Executive Employment Agreement, dated June 11, 2018, by and between the Company and David Hasting (Filed With SEC on March 7, 2019)
- Executive Employment Agreement, dated October 8, 2018, by and between Arbutus Biopharma, Inc. and Gaston Picchio (Filed With SEC on November 7, 2018)
- Executive Employment Agreement Transfer between Arbutus Biopharma Corporation and Koert VandenEnden., dated February 16, 2018 (Filed With SEC on March 16, 2018)
- Termination and Severance Agreement between Arbutus Biopharma Corporation and Bruce Cousins, dated February 8, 2018 (Filed With SEC on March 16, 2018)
- ARBUTUS BIOPHARMA CORPORATION 2016 OMNIBUS SHARE AND INCENTIVE PLAN (Filed With SEC on August 4, 2016)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 9, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 9, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- Confidential treatment has been requestedfor portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions... (Filed With SEC on August 7, 2015)
- Confidential treatment has been requested forportions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on August 7, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on May 6, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on May 6, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 13, 2015)
- Executive Employment Agreement, dated July 10, 2015, by and between Arbutus Biopharma, Inc. and Michael McElhaugh, as amended by the First Amendment to Executive Employment... (Filed With SEC on August 5, 2019)
